What’s Mine is Mine, What’s Yours is Mine: Ownership, Licensing, and Double Patenting Eric MyersJuly 6, 2020
Dr. Grüneberg again achieves top listing in competitive IAM 1000 rankings firm, KGEric MyersJune 22, 2020
Royal Society of Chemistry publication quotes Dr. Richard Chinn on patent claim construction firmEric MyersJune 18, 2020
USPTO Accepting Initial Patent Term Extension (PTE) Applications Electronically, in View of COVID-19 Outbreak myersEric MyersMay 30, 2020
If you want it, claim it: doctrine of equivalents prevented from covering disclosed alternatives myersEric MyersMay 11, 2020
Pre-diagnostic preparation method found subject-matter eligible on appeal myersEric MyersMarch 23, 2020
During ongoing COVID-19 concerns, government agencies adapt while firm operations continue firmEric MyersMarch 16, 2020
Federal Circuit uses specification and prosecution history to nail down claim interpretation myersEric MyersMarch 15, 2020
On International Women’s Day, the Firm Celebrates Women in Law, Science, and Engineering firmEric MyersMarch 7, 2020
Prior Art References Combined to Knock Out a Patented Treatment Method, Even as Limited by Pharmacokinetics myersEric MyersDecember 30, 2019
Supreme Court Urged to Reconsider Patent Eligibility Approach—Just Not This Time myersEric MyersDecember 7, 2019
Prosecution History Estoppel Bars Infringement under the Doctrine of Equivalents Eric MyersNovember 27, 2019
Grüneberg and Myers Team Expands with Addition of Experienced Biotech Associate firmEric MyersNovember 12, 2019
Cancer Treatment Patent Survives, Even Over Earlier Evidence of Phase II Trials Eric MyersOctober 6, 2019
